Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 10 | 2016 | 5146 | 0.540 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2017 | 120 | 0.520 |
Why?
|
| Cardiac Resynchronization Therapy | 2 | 2018 | 552 | 0.470 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2011 | 1849 | 0.300 |
Why?
|
| Catheter Ablation | 2 | 2011 | 2724 | 0.300 |
Why?
|
| Aneurysm, False | 1 | 2010 | 258 | 0.290 |
Why?
|
| Heat-Shock Proteins | 1 | 2011 | 797 | 0.280 |
Why?
|
| Saphenous Vein | 1 | 2010 | 527 | 0.280 |
Why?
|
| Shock, Cardiogenic | 1 | 2010 | 715 | 0.230 |
Why?
|
| Growth Differentiation Factor 15 | 2 | 2015 | 184 | 0.210 |
Why?
|
| Glucocorticoids | 1 | 2011 | 2146 | 0.190 |
Why?
|
| Coronary Artery Bypass | 1 | 2010 | 2265 | 0.180 |
Why?
|
| Heart Failure | 2 | 2017 | 11725 | 0.170 |
Why?
|
| Osteopontin | 2 | 2010 | 300 | 0.150 |
Why?
|
| Electrodes, Implanted | 1 | 2021 | 824 | 0.140 |
Why?
|
| Coronary Disease | 1 | 2011 | 5995 | 0.130 |
Why?
|
| Device Removal | 1 | 2021 | 635 | 0.130 |
Why?
|
| Relaxin | 1 | 2013 | 41 | 0.110 |
Why?
|
| Neuregulin-1 | 1 | 2014 | 135 | 0.110 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2016 | 607 | 0.100 |
Why?
|
| Defibrillators, Implantable | 2 | 2021 | 1478 | 0.100 |
Why?
|
| Prosthesis Implantation | 1 | 2017 | 590 | 0.100 |
Why?
|
| Health Status Indicators | 1 | 2015 | 968 | 0.090 |
Why?
|
| Tachycardia, Ventricular | 1 | 2018 | 1292 | 0.080 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2010 | 1692 | 0.080 |
Why?
|
| Nicotine | 2 | 2010 | 676 | 0.080 |
Why?
|
| Carcinogens | 1 | 2010 | 448 | 0.080 |
Why?
|
| Vitamin D Deficiency | 1 | 2016 | 1368 | 0.070 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 1921 | 0.070 |
Why?
|
| Constriction, Pathologic | 1 | 2010 | 1099 | 0.070 |
Why?
|
| Pulmonary Veins | 1 | 2011 | 732 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2010 | 1828 | 0.060 |
Why?
|
| Patient Selection | 1 | 2017 | 4238 | 0.060 |
Why?
|
| Secondary Prevention | 1 | 2011 | 1546 | 0.060 |
Why?
|
| Heart Atria | 1 | 2010 | 1339 | 0.060 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2010 | 1109 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 2 | 2010 | 5288 | 0.050 |
Why?
|
| Recurrence | 1 | 2011 | 8420 | 0.040 |
Why?
|
| Humans | 16 | 2021 | 752341 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2010 | 4543 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2016 | 23783 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 15676 | 0.040 |
Why?
|
| Lasers | 1 | 2021 | 952 | 0.030 |
Why?
|
| Sepsis | 1 | 2010 | 2588 | 0.030 |
Why?
|
| Pacemaker, Artificial | 1 | 2021 | 812 | 0.030 |
Why?
|
| Probucol | 1 | 2014 | 25 | 0.030 |
Why?
|
| Prognosis | 2 | 2016 | 29327 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2016 | 9701 | 0.030 |
Why?
|
| Equipment Design | 1 | 2021 | 3510 | 0.030 |
Why?
|
| Incidence | 1 | 2011 | 21158 | 0.030 |
Why?
|
| PPAR gamma | 1 | 2014 | 484 | 0.020 |
Why?
|
| Aged | 5 | 2018 | 166562 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 12152 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3463 | 0.020 |
Why?
|
| Risk Factors | 4 | 2018 | 73412 | 0.020 |
Why?
|
| Female | 7 | 2021 | 386053 | 0.020 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2014 | 1002 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2014 | 1424 | 0.020 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 1515 | 0.020 |
Why?
|
| Computers, Handheld | 1 | 2009 | 209 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2010 | 632 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 20348 | 0.020 |
Why?
|
| Middle Aged | 5 | 2021 | 217019 | 0.020 |
Why?
|
| Male | 6 | 2021 | 354881 | 0.020 |
Why?
|
| Forecasting | 1 | 2013 | 2916 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2009 | 1694 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2014 | 3050 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2010 | 16736 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2010 | 64245 | 0.010 |
Why?
|
| United States | 1 | 2011 | 71442 | 0.010 |
Why?
|
| Disease Management | 1 | 2013 | 2479 | 0.010 |
Why?
|
| Animals | 2 | 2013 | 166802 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2010 | 1716 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12137 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2009 | 6137 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 14586 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2010 | 2625 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 3468 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 15130 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 11007 | 0.010 |
Why?
|
| Time Factors | 1 | 2016 | 39854 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2009 | 12738 | 0.010 |
Why?
|
| Smoking | 1 | 2009 | 9029 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 79127 | 0.010 |
Why?
|
Concepts
(84)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_